Latest Administration News

NeuroScientific Biopharmaceuticals reports encouraging clinical responses in fistulising Crohn’s disease patients treated under Australia’s Special Access Scheme, setting the stage for pivotal Phase 2 trials later this year.

Elevra Lithium unveils a staged, accelerated expansion plan for its North American Lithium mine, aiming to increase spodumene concentrate production to 315ktpa by early 2029 while lowering operating costs.

Revolver Resources has unveiled a compelling recommencement study for its Dianne Copper Mine in Queensland, forecasting over $125 million in pre-tax free cashflow from a four-year operation producing 14,330 tonnes of high-grade copper cathode.

Pharmaceutical manufacturer ANO has been hit with a US FDA Import Alert, joining several Australian peers amid wider regulatory tensions. The company is mobilising expert consultants and preparing a petition to lift the alert within weeks.

Nyrada has secured ethics approval to begin a pivotal Phase IIa trial of its drug Xolatryp, targeting heart attack damage. Patient dosing is set to start in March 2026 across multiple Australian hospitals.

RocketBoots Limited has responded to ASX concerns over a delayed director interest disclosure, attributing the lapse to an administrative oversight during a holdings restructure. The company affirms its compliance policies and has taken steps to prevent future delays.

Elsight Limited has secured a US$460,000 purchase order from a U.S. public safety customer, marking a significant commercial milestone amid accelerating FAA regulations for drone operations beyond visual line of sight.

Lindian Resources reports strong construction progress at its Kangankunde Rare Earths Project in Malawi, highlighted by the arrival of its Komatsu owner-operator mining fleet and advancing infrastructure works.

Neuren Pharmaceuticals has published promising Phase 2 trial results for NNZ-2591 in Phelan-McDermid syndrome, underpinning its ongoing Phase 3 Koala trial recruiting in the US.

Mount Hope Mining Limited has explained the late lodgement of director interest disclosures as an administrative oversight, responding to ASX concerns over potential compliance breaches.

Mineral Commodities Limited has made its CEO role redundant following the appointment of voluntary administrators, signalling deep restructuring ahead.

Adisyn Ltd has successfully demonstrated low-temperature deposition of an sp²-based carbon layer using Atomic Layer Deposition, a milestone independently verified and critical for semiconductor integration.